Selective and antigen-dependent effects of myelin degeneration on central nervous system inflammation

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 12, 2004, Pages 1284-1296

  Aboul Enein, Fahmy ^a   Bauer, Jan ^a   Klein, Matthias ^b   Schubart, Anna ^b   Flügel, Alexander ^b   Ritter, Thomas ^c   Kawakami, Naoto ^b   Siedler, Frank ^d   Linington, Christopher ^b   Wekerle, Hartmut ^b   Lassmann, Hans ^a   Bradl, Monika ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Antigen; Degeneration; Demyelination; Inflammation; Myelin; Transgenic rats

Indexed keywords

MYELIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DEMYELINATION; DISEASE SEVERITY; ENCEPHALITIS; INFLAMMATION; LYMPHOCYTE COUNT; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE DEGENERATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TRANSGENIC ANIMAL;

EID: 10044249878     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.12.1284     Document Type: Article

References (29)

1. Bradl M, Linington C. Animal models of demyelination. Brain Pathol 1996;6:303-11
2. Powers JM, Liu Y, Moser AB, Moser HW. The inflammatory myelinopathy of adreno-leukodystrophy: Cells, effector molecules, and pathogenic implications. J Neuropathol Exp Neurol 1992;51:630-43
3. Lucchinetti C, Bruck W, Rodrigues M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol 1996;6:259-74
4. Bradl M, Bauer J, Inomata T, et al. Transgenic Lewis rats overexpressing the proteolipid protein gene: Myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis. Acta Neuropathol (Berl) 1999;97:595-606
5. Bauer J, Bradl M, Klein M, et al. Endoplasmic reticulum stress in PLP-overexpressing transgenic rats: Gray matter oligodendrocytes are more vulnerable than white matter oligodendrocytes. J Neuropathol Exp Neurol 2002;61:12-22
6. Ben Nun A, Wekerle H, Cohen IR. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 1981;11:195-99
7. Schluesener HJ, Wekerle H. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: In vitro selection from unprimed rat T lymphocyte populations. J Immunol 1985;135:3128-33
8. Zhao W, Wegmann KW, Trotter JL, Ueno K, Hickey WF. Identification of an N-terminally acetylated encephalitogenic epitope in myelin proteolipid apoprotein for the Lewis rat. J Immunol 1994;153:901-9
9. Bourquin C, Iglesias A, Berger T, Wekerle H, Linington C. Myelin oligodendrocyte glycoprotein-DNA vaccination induces antibody-mediated autoaggression in experimental autoimmune encephalomyelitis. Eur J Immunol 2000;30:3663-71
10. Linington C, Bradl M, Lassmann H, Brunner C, Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/ oligodendrocyte glycoprotein. Am J Path 1988;130:443-54
11. Flugel A, Willem M, Berkowicz T, Wekerle H. Gene transfer into CD4+ T lymphocytes: Green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nat Med 1999;5:843-47
12. Flugel A, Berkowicz T, Ritter T, et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 2001;14:547-60
13. Kawakami N, Lassmann S, Li Z, et al. The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J Exp Med 2004;199:185-97
14. Flugel A, Bradl M. New tools to trace populations of inflammatory cells in the CNS. Glia 2001;36:125-36
15. Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H. Experimental autoimmune encephalomyelitis: The antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 1997;76:355-64
16. Schneider SC, Sercarz EE. Antigen processing differences among APC. Human Immunology 1997;54:148-58
17. Hampton RY. ER-associated degradation in protein quality control and cellular regulation. Curr Opin Cell Biol 2002;14:476-82
18. Goldberg AL, Cascio P, Saric T, Rock KL. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol Immunol 2002;39:147-64
19. Rock KL, Goldberg AL. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol 1999;17:739-79
20. York IA, Mo AXY, Lemerise K, et al. The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity 2003;18:429-40
21. Hosseini H, Andre P, Lefevre N, et al. Protection against experimental autoimmune encephalomyelitis by a proteasome modulator. J Neuroimmunol 2002;118:233-44
22. Vanderlugt CL, Rahbe SM, Elliot PJ, Dal Canto MC, Miller SD. Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519. J Autoimmun 2000;14:205-11
23. Nakao J, Yamada M, Kagawa T, et al. Expression of proteolipid protein gene is directly associated with secretion of a factor influencing oligodendrocyte development. J Neurochem 1995;64:2396-403
24. Yamada M, Jung M, Tesushi K, Ivanova A, Nave KA, Ikenaka K. Mutant P1p/DM20 cannot be processed to secrete PLP-related oligodendrocyte differentiation/survival factor. Neurochem Res 2001;26:639-45
25. Yamada M, Ivanova A, Yamaguchi Y, Lees MB, Ikenaka K. Proteolipid protein gene product can be secreted and exhibit biological activity during early development. J Neurosci 1999;19:2143-51
26. Gardinier MV, Amiguet P, Linington C, Matthieu JM. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J Neurosci Res 1992;33:177-87
27. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW. Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 1999;30:77-105
28. Bagasra O, Michaels FH, Zheng YM, et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci U S A 1995;92:12041-45
29. Koprowski H, Zheng YM, Heber-Katz E, et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci U S A 1993;90:3024-27